Joseph Lau

Vancouver, BC V5Z1M9, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Unnatural Amino Acid Substitutions to Improve In Vivo GRPR-Targeting Capability of [68Ga]Ga-SP01011 for Cancer Imaging.

Unnatural Amino Acid Substitutions to Improve In Vivo GRPR-Targeting Capability of [68Ga]Ga-SP01011 for Cancer Imaging.

Journal: Molecular pharmaceutics
Published: June 21, 2026

Synthesis and evaluation of [68Ga]Ga-DOTA-Pip-PEP-4 derivatives for imaging gastrin-releasing peptide receptor expression with positron emission tomography.

Synthesis and evaluation of [68Ga]Ga-DOTA-Pip-PEP-4 derivatives for imaging gastrin-releasing peptide receptor expression with positron emission tomography.

Journal: Nuclear medicine and biology
Published: March 21, 2026

Development of an Optimized CXCR4-Targeting Theranostic Pair.

Development of an Optimized CXCR4-Targeting Theranostic Pair.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 25, 2025

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies.

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies.

Journal: Molecules (Basel, Switzerland)
Published: July 04, 2022

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX.

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX.

Journal: mAbs
Published: November 22, 2021

Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands.

Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 17, 2021

A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors.

A Systematic Review of Molecular Imaging Agents Targeting Bradykinin B1 and B2 Receptors.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 27, 2020

Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE.

Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE.

Journal: EJNMMI research
Published: December 30, 2019

[68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4.

[68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4.

Journal: Molecular pharmaceutics
Published: September 24, 2019

Comparison of biological properties of [177 Lu]Lu-ProBOMB1 and [177 Lu]Lu-NeoBOMB1 for GRPR targeting.

Comparison of biological properties of [177 Lu]Lu-ProBOMB1 and [177 Lu]Lu-NeoBOMB1 for GRPR targeting.

Journal: Journal of labelled compounds & radiopharmaceuticals
Published: August 06, 2019

Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies.

Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies.

Journal: Molecular pharmaceutics
Published: September 26, 2018

Effects of Linker Modification on Tumor-to-Kidney Contrast of 68Ga-Labeled PSMA-Targeted Imaging Probes.

Effects of Linker Modification on Tumor-to-Kidney Contrast of 68Ga-Labeled PSMA-Targeted Imaging Probes.

Journal: Molecular pharmaceutics
Published: June 20, 2018
Showing 1-12 of 39

Last Updated: 09/26/2026